Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Biomarkers Market

Veterinary Biomarkers Market Share

Report ID: GMI10491
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Veterinary Biomarkers Market Share

The veterinary biomarkers industry features a variety of companies competing to improve diagnostic precision and broaden their range of products. These companies are primarily focusing on strategies such as developing rapid and sensitive biomarker tests, expanding their global footprint, and forming partnerships to advance technology. Moreover, to strengthen their competitive position the companies are intensely focusing on meeting diverse veterinary requirements, spanning from companion animal health to livestock management, while managing regulatory complexities and promoting economically viable solutions.

Veterinary Biomarkers Market Companies

Few of the prominent players operating in the veterinary biomarkers industry include:

Bio-Rad Laboratories, Inc.
Biomerieux SA
Bionote USA Inc.
CUSABIO TECHNOLOGY LLC
EagleBio
Gentian Diagnostics ASA
IDEXX Laboratories Inc.
Krishgen Biosystems
Life Diagnostics, Inc.
Merck KGaA
Randox Laboratories Ltd.
Virbac
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The veterinary biomarkers market size was valued at USD 798.5 million in 2023 and is estimated to grow at 9.9% CAGR from 2024 to 2032 due to the increasing awareness and emphasis on early disease diagnosis.

The companion animal segment in the market generated USD 523.5 million in 2023 owing to need for diagnosing and managing health conditions.

North American veterinary biomarkers market accounted for USD 333.4 million in 2023 due to highest rate of pet ownership globally.

Bio-Rad Laboratories, Inc., Biomerieux SA, Bionote USA Inc., CUSABIO TECHNOLOGY LLC, EagleBio, Gentian Diagnostics ASA, IDEXX Laboratories Inc., and Krishgen Biosystems